Related Experiment Video
Updated: Apr 30, 2026
07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
1.1K
[Nephroprotective properties of third-generation beta-adrenoblockers]
Eksperimental'Naia I Klinicheskaia Farmakologiia
|May 8, 2014
Summary
Third-generation beta-blockers like nebivolol and carvedilol protect kidneys by lowering blood pressure and reducing oxidative stress in kidney tissues. These effects are crucial for maintaining renal health.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Kidney disease is a significant health concern.
- Oxidative stress contributes to renal damage.
- Third-generation beta-blockers offer potential therapeutic benefits.
Purpose of the Study:
- To review the nephroprotective properties of nebivolol and carvedilol.
- To explore the mechanisms underlying their kidney-protective effects.
Main Methods:
- Review of experimental and clinical data.
- Analysis of drug effects on blood pressure.
- Assessment of oxidative stress markers in renal tissues.
Main Results:
- Nebivolol and carvedilol demonstrate nephroprotector properties.
- Antihypertensive effects contribute to kidney protection.
- Suppression of oxidative stress in glomeruli, tubules, and interstitial tissue observed.
Conclusions:
- Nebivolol and carvedilol show promise in protecting kidney function.
- Their mechanisms involve both blood pressure reduction and antioxidant effects.
- Further research into these beta-blockers for renal protection is warranted.
More Related Videos
Related Concept Videos
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.4K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
01:22Heart Failure Drugs: β-Blockers
2.7K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
01:28Antihypertensive Drugs: Types of β-Blockers
2.0K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
2.0K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
01:17Antihypertensive Drugs: Action of β1 Blockers
2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K